Pravin Singhal is a Nephrology physician affiliated with Feinstein Institute for Medical Research. OpenAlex indexes 393 publications with 11,854 citations (h-index 54). By OpenAlex citation count, this profile ranks in the top 10% of Nephrology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
410 Lakeville Rd
New Hyde Park, NY 110421101
Telephone
516-465-5260Registry record last updated 8 Jul 2007.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20251 payment
- GlaxoSmithKline, LLC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
53.2%Loop diuretic15.2%Furosemide78%Torsemide22%Part D≥44 patientsCalcium channel blocker11.5%Amlodipine Besylate55%Nifedipine Er27%Diltiazem 24hr Er (Cd)17%Part D<11 patients+ 9 more classes in this area
Metabolism & gastrointestinal
24%SGLT2 inhibitor13.4%Farxiga80%Jardiance20%Part D≥56 patientsH2 blocker2.2%Famotidine100%Part D≥11 patients+ 6 more classes in this area
Blood & clotting
7.7%Solutions for parenteral nutrition7.7%Calcium Acetate100%Part D≥24 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 1991–2021 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prevalence and outcomes of hyponatremia and hypernatremia in patients hospitalized with COVID-19
Nephrology Dialysis Transplantation
2021 - Outcomes of patients with end-stage kidney disease hospitalized with COVID-19
Kidney International
2020 - Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury
American Journal of Kidney Diseases
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Nicholas Chiorazzi, MD
Feinstein Institute for Medical Research
Houman Khalili, MD
Feinstein Institute for Medical Research
Luca Giliberto, MD, PhD
Feinstein Institute for Medical Research
Albert Fenoy, MD
Feinstein Institute for Medical Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”